ASLN long - upcoming catalystsThis is not a financial advice! Vol . is slowly increasing SL under 0.3 TP 1.8 to 2.0 Most info on the chart. Trade carefully!Longby meitshelUpdated 113
🟢 $ASLN Target 5.37 for 32.27% 🟢 $ASLN Target 5.37 for 32.27% Or double position at 2.75 — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from there as needed and as possible. I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed. GL and happy trading. I finally added my YouTube Training Video to my profile tagline since I’m not allowed to on here. It’s a quick 15 minute training video on how to set up your chart and how to spot opportunities. So check here first but If you have questions just message me. Longby SPYder_QQQueen_Trading1
$ASLN can rise in the next daysContextual immersion trading strategy idea. ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $4,46; stop-loss — $3,72. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!Longby KozakHlibUpdated 111
$ASLN AV. 5.58 -----> target 6.89 for 23.48%Well, I had to add again. Obviously I like my momentum trades to be executed within one day however sometimes you half to hold it a little bit longer so my average is at 5.58 ----> target 6.89 for 23.48% Next level to add is at 4.27, and I'll update if I add any... Longby SPYder_QQQueen_Trading2
$ASLN Average Down Hit... New targetWell my average down was hit, so now 6.13 ——> 7.44 for 21.37% Double position at 4.82 is the plan... Let's see what happens... Longby SPYder_QQQueen_Trading222
$ASLMN Morning Momentum Swing... 6.79 ——> 8.10 for 19.29%In at 6.79 ——> Target 8.10 for 19.29% If it pulls back more, double position at 5.48 Follow me if you want, but I am not your financial advisor... Longby SPYder_QQQueen_TradingUpdated 334
ASLAN Pharmaceuticals Announces $18 Million Private PlacementASLAN Pharmaceuticals Announces $18 Million Private Placement ASLAN today announced that it has entered into a securities purchase agreement to raise gross proceeds of approximately $18 million resulting from the sale of its ordinary shares through a private placement to new institutional investors, Vivo Capital and Surveyor Capital (a Citadel company). the Company will issue an aggregate of 25,568,180 ordinary shares (equivalent to 5,113,636 American Depositary Shares (“ADSs”)) at an equivalent price of $3.52 per ADS, equal to the last closing price of the Company’s ADSs. The Company intends to use the net proceeds from the private placement primarily to advance clinical development of ASLAN004, as well as for general corporate purposes. “These additional resources position us well as we look forward to unblinding the interim data from our ongoing study of ASLAN004 in atopic dermatitis in early March and look towards initiating our phase 2b program later in 2021.” finance.yahoo.comby AlenCiken2
ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDAASLN: ASLAN Pharmaceuticals 2018-08-20 02:49:00 ASLAN Pharmaceuticals Granted Orphan Drug Designation by the FDA for ASLAN003 for the Treatment of Acute Myeloid LeukaemiaLongby RocketTickers3